Matthew Hall holds a Ph.D. in Biology from the University of Lausanne. He has applied his knowledge over the past years in the Next Generation Sequencing biotechnology industry.
Pedro Faustino holds an EMBA in Management of Technology from both the Swiss Federal Institute of Technology in Lausanne (EPFL) and HEC Lausanne. He has held several technical positions in various technology-based multinational companies.
Imran Fanaswala holds degrees in Bioinformatics (ETH Zurich) and Computer Science (AUS). He brings his experience in machine learning, bioinformatics, and a passion for meeting deadlines with clean code.
Miguel Barreto holds a Ph.D. in Information Systems from Lausanne University. He is an expert in machine learning and bioinformatics.
Vincent Bieri is co-founder and board member at Nexthink SA. He brings his knowledge in sales, marketing strategy and SaaS software product management in Analytics and Big Data.
Vincent Mutel is CEO, co-founder and board member at Inflamalps SA. He was co-founder, CEO and vice chairman of the board at Addex Pharmaceuticals SA. He brings his biotech market knowledge and experience in corporate governance.
Prof. Carlos Peña is a Professor in Computer Engineering at the University of Applied Sciences, Western Switzerland. His central professional interest concerns the possible, different, interfaces between life and engineering sciences.
Prof. Manuel Peitsch is the co-founder and the chairman of the Board of the Swiss Institute of Bioinformatics. Manuel Peitsch is CSO and VP for "Biological Systems Research" at Philip Morris International R&D. Manuel joined PMI R&D after 8 years at Novartis.
Medical doctor Thomas Matthes, is associated professor at the Geneva University Hospital and director of the Swiss school of Flow cytometry. His deep knowledge of oncology and haematology, gives him a first hand insight of the problems faced when looking to diagnose complex diseases.